Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway

BACKGROUND: Immune checkpoint inhibitors are the most studied forms of immunotherapy for triple-negative breast cancer (TNBC). The Cancer Genome Map (TCGA) and METABRIC project provide large-scale cancer samples that can be used for comprehensive and reliable immunity-related gene research. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Ying, Li, Fangyuan, Zhang, Sumei, Yang, Zhenli, Ren, Xinyu, Cao, Xi, Xu, Yali, Guo, Dan, Zhou, Yidong, Mao, Feng, Shen, Songjie, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111802/
https://www.ncbi.nlm.nih.gov/pubmed/37069585
http://dx.doi.org/10.1186/s12935-023-02917-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111802/
https://www.ncbi.nlm.nih.gov/pubmed/37069585
http://dx.doi.org/10.1186/s12935-023-02917-7

Ejemplares similares